We want to assure you that the we are here for you. While the coronavirus has changed much of our daily lives, one thing that has remained constant is our commitment to providing you with the best, safest care possible.
At the Lifespan Cancer Institute, your safety is our top priority. As experts in cancer, we also know completing a treatment plan is associated with the best outcomes for patients. That is why we worked closely with our infection prevention and infectious diseases teams to be able to provide the care you need in a safe environment.
At Lifespan Cancer Institute’s Hematologic Malignancies Center, our team of experts provides comprehensive patient-centered care and innovative treatments for adult patients with blood disorders (hematology) or blood cancer (oncology).
Our physicians work collaboratively to diagnose, treat, and prevent diseases and cancers of the blood, enabling our patients to benefit from the expertise of the hematopathologist, radiologist, and medical oncologist from the very first visit.
Contact the Lifespan Cancer Institute
To schedule an appointment with the Lifespan Cancer Institute, please call 1-844-222-2881.
At Rhode Island Hospital and The Miriam Hospital, outpatient facilities provide diagnosis and treatment of the full spectrum of hematologic and oncologic disorders.
Dedicated inpatient units at both hospitals give our patients specialized care to meet their particular needs while they are being treated for hematology oncology. A HEPA-filtered, state-of-the-art environment in private rooms at Rhode Island Hospital protects immune-compromised patients against infectious diseases.
Meet the Team
A hematologist-oncologist is a physician who has been trained in the study of blood (hematology) and the study of cancer (oncology).
Our team of highly skilled specialists provides comprehensive care and innovative treatments to pediatric and young adult patients with blood disorders or cancer.
Research and Clinical Trials
Learn more about the innovative cancer research and treatments at the Lifespan Cancer Institute.